First quarter results put Herbalife in focus

Herbalife (HLF) reported first quarter sales of US$1,317.2 million and net income of US$61.9 million, with earnings per share from continuing operations ahead of the figures reported a year earlier.

Herbalife's earnings release landed alongside concerns about higher input costs across the personal care sector, and the stock's recent 1 day share price return of an 11.86% decline contrasts with a very large 1 year total shareholder return, suggesting momentum has cooled in the short term while longer term returns remain strong.

If Herbalife's recent moves have you thinking about what else is out there, it could be worth scanning 18 top founder-led companies

With earnings per share moving higher than last year and the stock still showing a very large 1 year total return, the key question is whether Herbalife is now attractively valued after the pullback or if the market has already incorporated expectations of future growth into the price.

Most Popular Narrative: 17.2% Undervalued

Herbalife's most followed narrative pegs fair value at $17.50, above the last close of $14.49, putting the recent pullback in a different light for valuation focused investors.

Investors may be underestimating the risk of increasing global regulatory scrutiny on multi-level marketing (MLM) models and nutritional supplement claims, which could raise compliance costs, limit distributor activity in key regions, and constrain Herbalife's long-term revenue and earnings growth. Secular consumer trends toward whole, natural foods and growing skepticism of processed supplements may impair demand for Herbalife's core products, potentially leading to slower revenue growth and higher customer acquisition costs as consumer preferences evolve.

Curious how that risk heavy backdrop still supports an above market earnings profile and a higher future profit margin baked into fair value assumptions? The narrative leans on a specific revenue trajectory, a tighter margin outlook, and a modest future P/E that sits well below the broader personal products industry. Yet it still lifts the valuation above today's price. The tension between slower forecast growth and a higher implied value is where the story gets interesting.

Result: Fair Value of $17.50 (UNDERVALUED)

However, if Herbalife's push toward a more data driven wellness model gains traction, or if recent volume momentum in key markets broadens, this risk skew could quickly look different.

Next Steps

With sentiment split between risks and rewards, it helps to move quickly, review the underlying numbers, and decide where you stand using the 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If Herbalife has caught your attention, do not stop there. Use the Simply Wall Street Screener to size up other opportunities and keep your watchlist working harder for you.

• Target potential value opportunities by checking out 51 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect them.
• Prioritise resilience by scanning 72 resilient stocks with low risk scores that score well on financial strength and risk metrics.
• Spot potential future standouts early by reviewing the screener containing 23 high quality undiscovered gems before they sit firmly on every investor's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.